Scientific Sessions 2025  /  Recipes for Success in Heart Failure  /  Discussant: POLY-HF
Logo

American Heart Association

  87
  0

Final ID:

Discussant: POLY-HF

  • Vardeny, Orly  ( Minneapolis VA Health Care System , Minneapolis , Minnesota , United States )
    • Author Disclosures:
    Orly Vardeny: DO have relevant financial relationships ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Advisor:Moderna:Past (completed) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:Novonordisk:Active (exists now) ; Advisor:Cardior:Past (completed) ; Research Funding (PI or named investigator):Cardurion:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Recipes for Success in Heart Failure

Monday, 11/10/2025 , 09:45AM - 11:00AM

Late-Breaking Science

More abstracts on this topic:
Cardiac Allograft Vasculopathy Inhibition with AliRocumab:
The CAVIAR Trial

Fearon William, Terada Kossei, Skoda Anette, Luikart Helen, Knowles Josh, Honda Yasuhiro, Woo Christopher, Teuteberg Jeffrey, Khush Kiran

Once-weekly Tirzepatide versus Dulaglutide for Heart Failure Outcomes in Patients with Type 2 Diabetes, ASCVD, and History of Heart Failure (pre-specified analysis of the SURPASS-CVOT Randomized Clinical Trial)

Nicholls Stephen, Dalessio David

More abstracts from these authors:
Discussant: NUDGE-FLU

Vardeny Orly

Educational Attainment Level and Risk of Mortality and Cardiopulmonary Outcomes in High-Risk Cardiovascular Disease Patients: The INVESTED Trial

Lassen Mats, Howell Nicholas, Claggett Brian, Biering-srensen Tor, Vardeny Orly, Solomon Scott, Udell Jacob, Joseph Jacob, Hegde Sheila

You have to be authorized to contact abstract author. Please, Login
Not Available